Royal Bank of Canada
TGAN

Royal Bank of Canada’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Royal Bank of Canada’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,156
Closed -$10K – 7726
2024
Q1 		$10K Sell
2,156
-18,808
-90% -$89.3K ﹤0.01% 6225
2023
Q4 		$77K Buy
20,964
+17,441
+495% +$47.8K ﹤0.01% 5769
2023
Q3 		$8K Buy
3,523
+1,845
+110% +$5.15K ﹤0.01% 6509
2023
Q2 		$6K Buy
1,678
+227
+16% +$819 ﹤0.01% 6642
2023
Q1 		$6K Sell
1,451
-2,092
-59% -$9.21K ﹤0.01% 6528
2022
Q4 		$20K Buy
3,543
+3,266
+1,179% +$19.2K ﹤0.01% 6306
2022
Q3 		$1K Buy
277
+157
+131% +$773 ﹤0.01% 7325
2022
Q2 		$0 Sell
120
-7,549
-98% -$48.2K ﹤0.01% 7851
2022
Q1 		$54K Buy
+7,669
New +$53.9K ﹤0.01% 6043

Royal Bank of Canada's TGAN Position: Q2 2024 in Review

Royal Bank of Canada sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 2,156 shares — an estimated $10K sold.

Royal Bank of Canada first reported a position in TGAN in Q1 2022 and held it in 9 quarters. The position peaked at $77K in Q4 2023. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

  • Royal Bank of Canada reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2,156 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $10K.
  • Royal Bank of Canada first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • Royal Bank of Canada's Transphorm, Inc. Common Stock position peaked at $77K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.